Outcomes of Minority COVID-19 patients managed with ECMO: A single-center experience.

ABSTRACT:

Background

The coronavirus disease 2019 (COVID-19) pandemic has significantly burdened the global healthcare system since December 2019. Minority populations are found to have a higher incidence of hospitalization and higher mortality when compared to Caucasians. Extracorporeal membrane oxygenation (ECMO) is reserved for COVID-19 patients who develop respiratory failure refractory to conventional management. To our knowledge, no data has been reported on outcome differences between Minority COVID-19 patients and Caucasian COVID-19 patients managed with ECMO. We aimed to investigate the outcome differences between these two groups.

Methods

Our retrospective cohort study had 23 adults (aged 18 and older) diagnosed with COVID-19 by polymerase chain reaction. All patients develo

SUBMITTER: Jones C 

PROVIDER: S-EPMC9115183 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature